1. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Issue 10189 (15th June 2019) Authors: Rini, Brian I; Powles, Thomas; Atkins, Michael B; Escudier, Bernard; McDermott, David F; Suarez, Cristina; Bracarda, Sergio; Stadler, Walter M; Donskov, Frede; Lee, Jae Lyun; Hawkins, Robert; Ravaud, Alain; Alekseev, Boris; Staehler, Michael; Uemura, Motohide; De Giorgi, Ugo; Mellado, Begoña; Por... Journal: Lancet Issue: Volume 393:Issue 10189(2019) Page Start: 2404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 19 Stereotactic Body Radiotherapy for Large Primary Large Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). (October 2019) Authors: Correa, Rohann J.M.; Siva, Shankar; Warner, Andrew; Staehler, Michael; Gandhihassan, Senthilkumar; Ponsky, Lee; Ellis, Rodney; Kaplan, Irving; Mahadevan, Anand; Chu, William; Swaminath, Anand; Onishi, Hiroshi; Teh, Bin S.; Lo, Simon S.; Muacevic, Alexander; Louie, Alexander V. Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial. Issue 4 (18th August 2020) Authors: Staehler, Michael; Panic, Andrej; Goebell, Peter J.; Merling, Marie; Potthoff, Karin; Herrmann, Edwin; de Geeter, Patrick; Vannier, Corinne; Hogrefe, Cathrin; Marschner, Norbert; Grünwald, Viktor Journal: International journal of cancer Issue: Volume 148:Issue 4(2021) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma. (March 2016) Authors: Siva, Shankar; Ellis, Rodney J; Ponsky, Lee; Teh, Bin S; Mahadevan, Anand; Muacevic, Alexander; Staehler, Michael; Onishi, Hiroshi; Wersall, Peter; Nomiya, Takuma; Lo, Simon S Journal: Future oncology Issue: Volume 12:Number 5(2016) Page Start: 637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study. (2nd January 2022) Authors: Schmidinger, Manuela; Motzer, Robert J.; Rolland, Frederic; Staehler, Michael; Rink, Michael; Retz, Margitta; Csoszi, Tibor; McCaffrey, John A.; De Giorgi, Ugo; Caserta, Claudia; Duran, Ignacio; Benzaghou, Fawzi; Clary, Douglas O.; Albiges, Laurence; Choueiri, Toni K.; Tannir, Nizar M. Journal: Acta oncologica Issue: Volume 61:Number 1(2022) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial. Issue 7 (26th October 2020) Authors: Staehler, Michael; Stöckle, Michael; Christoph, Daniel C.; Stenzl, Arnulf; Potthoff, Karin; Grimm, Marc‐Oliver; Klein, Dunja; Harde, Johanna; Brüning, Fabian; Goebell, Peter J.; Augustin, Marinela; Roos, Frederik; Benz‐Rüd, Iris; Marschner, Norbert; Grünwald, Viktor Journal: International journal of cancer Issue: Volume 148:Issue 7(2021) Page Start: 1685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney). Issue 12 (December 2022) Authors: Siva, Shankar; Ali, Muhammad; Correa, Rohann J M; Muacevic, Alexander; Ponsky, Lee; Ellis, Rodney J; Lo, Simon S; Onishi, Hiroshi; Swaminath, Anand; McLaughlin, Mark; Morgan, Scott C; Cury, Fabio L; Teh, Bin S; Mahadevan, Anand; Kaplan, Irving D; Chu, William; Grubb, William; Hannan, Raquibul; St... Journal: Lancet oncology Issue: Volume 23:Issue 12(2022) Page Start: 1508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PD18-11 FIRST IN-HUMAN RESULTS OF 68GA-EMP-100 PET FOR IMAGING C-MET EXPRESSION IN RENAL CELL CARCINOMA. (May 2022) Authors: Staehler, Michael; Schott, Melanie; Tamalunas, Alexander; Stief, Chistian; Graser, Annabel; Rodler, Severin; Unterrainer, Lena; Bartenstein, Peter Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PD15-10 LONG TERM FOLLOW UP IN PATIENTS UNDERGOING RENAL BIOPSY - SEEDING IS NOT ANECDOTAL. (May 2022) Authors: Staehler, Michael; Schott, Melaine; Tamalunas, Alexander; Stief, Chistian; Graser, Annabel; Rodler, Severin Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 44: Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multi-Centre Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK). (September 2022) Authors: Correa, Rohann; Siva, Shankar; Muhammad, Ali; Muacevic, Alexander; Ponsky, Lee; Ellis, Rodney; Lo, Simon S.; Onishi, Hiroshi; Swaminath, Anand; Mclaughlin, Mark; Morgan, Scott; Cury, Fabio; Teh, Bin S.; Mahadevan, Anand; Kaplan, Irving; Chu, William; Hannan, Raquibul; Staehler, Michael; Warner, A... Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗